These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3512601)

  • 1. The source of the circulating aggregate of insulin in type I diabetic patients is therapeutic insulin.
    Maislos M; Mead PM; Gaynor DH; Robbins DC
    J Clin Invest; 1986 Mar; 77(3):717-23. PubMed ID: 3512601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free covalent aggregates of therapeutic insulin in blood of insulin-dependent diabetics.
    Robbins DC; Mead PM
    Diabetes; 1987 Feb; 36(2):147-51. PubMed ID: 3542642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Products of therapeutic insulins in the blood of insulin-dependent (type I) diabetic patients.
    Robbins DC; Shoelson SE; Tager HS; Mead PM; Gaynor DH
    Diabetes; 1985 May; 34(5):510-9. PubMed ID: 3886464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic model of circulating covalent aggregates of insulin.
    Maislos M; Bialer M; Mead PM; Robbins DC
    Diabetes; 1988 Aug; 37(8):1059-63. PubMed ID: 3292326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.
    Tessari P; Nosadini R; Trevisan R; De Kreutzenberg SV; Inchiostro S; Duner E; Biolo G; Marescotti MC; Tiengo A; Crepaldi G
    J Clin Invest; 1986 Jun; 77(6):1797-804. PubMed ID: 3519679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes.
    Yki-Järvinen H; Koivisto VA
    J Clin Endocrinol Metab; 1984 Apr; 58(4):659-66. PubMed ID: 6365945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.
    Wredling R; Liu D; Lins PE; Adamson U
    Diabete Metab; 1991; 17(5):456-9. PubMed ID: 1752346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.
    Cernea S; Kidron M; Wohlgelernter J; Raz I
    Clin Ther; 2005 Oct; 27(10):1562-70. PubMed ID: 16330292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo insulin action in type 1 (insulin-dependent) diabetic pregnant women as assessed by the insulin clamp technique.
    Schmitz O; Klebe J; Møller J; Arnfred J; Hermansen K; Orskov H; Beck-Nielsen H
    J Clin Endocrinol Metab; 1985 Nov; 61(5):877-81. PubMed ID: 3900123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes.
    Schaller HC; Schaupp L; Bodenlenz M; Wilinska ME; Chassin LJ; Wach P; Vering T; Hovorka R; Pieber TR
    Diabet Med; 2006 Jan; 23(1):90-3. PubMed ID: 16409572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
    Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
    J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro stability of insulin lispro in continuous subcutaneous insulin infusion.
    DeFelippis MR; Bell MA; Heyob JA; Storms SM
    Diabetes Technol Ther; 2006 Jun; 8(3):358-68. PubMed ID: 16800757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lack of benefit from the intermittent administration of insulin in treatment using subcutaneous perfusion pump in type 1 diabetes].
    Lilet H; Krzentowski G; Bodson A; Scheen AJ; Lefebvre PJ
    Diabete Metab; 1991; 17(3):363-72. PubMed ID: 1884881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes.
    Paolisso G; Sgambato S; Torella R; Varricchio M; Scheen A; D'Onofrio F; Lefèbvre PJ
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1220-6. PubMed ID: 3286673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.